Impact Factor
2.65
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.04
372 total citations
h5-index
17
h5 depth signal
Cited share
51.6%
195 of 378
Total citations
372
Citation footprint
Metric signal
0.98
External metric anchor
Self-citation
1.9%
7 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,055
Turkey
349
India
213
Japan
165
Canada
145
Citing Fields of Research
Hematology
1,509
Oncology
517
Musculoskeletal & Nerve Cancer
291
Lymphomas
229
Palliative Care
141
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
8,675
Articles tracked across the journal lifetime
Indexed publication set
378
195 cited publications
Last 12 months
160
13.3 publications/month
Open access share
5.0%
8 OA publications in the last year
Leading citing country
United States
1,055 citing publications
Leading citing field
Hematology
1,509 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v17n1, 1995-
v17n1, 1995-
Active Coverage
Research Focus & Classification
Indexed Subjects
Hematology
Issuing & Sponsoring Bodies
Contributor
American Society of Pediatric Hematology/Oncology
Broad Categories
Hematology
Neoplasms
Pediatrics
MeSH Descriptors
Child
Hematologic Diseases
Infant
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/mph.0000000000003311
Open DOI
Clinical Heterogeneity of Class III MEK1 Mutations in Histiocytic Neoplasms: Insights From Adult and Pediatric Cases
02
DOI 10.1097/mph.0000000000003302
Open DOI
Real-World Use of Dinutuximab Beta for High-Risk Neuroblastoma in Clinical Settings in France: The QUATUOR Study
Dinutuximab beta (DB) is recommended for maintenance therapy in high-risk neuroblastoma (HR-NB) in Europe. In France, early access to DB was provided in the Temporary Use Authorization (ATU) program. The QUATUOR (Qarziba Use ATU Outcomes...
03
DOI 10.1097/mph.0000000000003304
Open DOI
Beyond Reirradiation: Third-Course Radiation Therapy in Recurrent Diffuse Intrinsic Pontine Glioma—Case Series and Literature Review
Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive brainstem tumor with a poor prognosis, for which radiotherapy remains the only established treatment. Although reirradiation at first progression has been reported to provide...
04
DOI 10.1097/mph.0000000000003300
Open DOI
Body Composition Assessment and Correlation to Metabolic Profile in Survivors of Childhood Brain Tumors
Introduction: Survivors of childhood brain tumors (CBT) are at increased risk for metabolic syndrome, contributing to long-term cardiometabolic morbidity. BMI may underestimate risk by failing to capture altered body composition in this ...
05
DOI 10.1097/mph.0000000000003307
Open DOI
Incidence and Predictors of Symptomatic Thrombosis During Asparaginase-containing Therapy in Children With Acute Lymphoblastic Leukemia
Objectives: Symptomatic thrombosis is a clinically important complication of asparaginase-containing therapy in children with acute lymphoblastic leukemia (ALL), but reported incidence and predictors vary across studies. We conducted a s...
06
DOI 10.1097/mph.0000000000003308
Open DOI
Howell-Jolly Body-Like Inclusions in Neutrophils and Monocytes of a Preterm Neonate During Sepsis
Was not provided for this article.
07
DOI 10.1097/mph.0000000000003279
Open DOI
Predictive Factors for Intensive Care Unit Admission in Children and Young Adults Undergoing Hematopoietic Cell Transplantation
Hematopoietic cell transplantation (HCT) carries significant morbidity and mortality. Defining factors that impact intensive care unit (ICU) admission rates in children and young adults undergoing HCT is required. Retrospective review of...
08
DOI 10.1097/mph.0000000000003301
Open DOI
Urolithiasis in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (ALL/LLy): A Single-Center Case Series of Clinical, Metabolic, and Imaging Features
Background: Urolithiasis is an underrecognized complication in pediatric acute lymphoblastic leukemia/lymphoma (ALL/LLy), often associated with glucocorticoid therapy. Observations: We report 4 cases of urolithiasis occurring at differen...
09
DOI 10.1097/mph.0000000000003299
Open DOI
Clarifications and Concerns Regarding the Manuscript “Comparing Iron Prophylaxis Strategies in Infants: Is Sucrosomial Iron a Better Alternative?”
Was not provided for this article.
10
DOI 10.1097/mph.0000000000003303
Open DOI
The Contribution of Bleeding Assessment Score and Pictorial Blood Loss Assessment Chart to the Diagnosis of Von Willebrand Disease in Adolescent Girls With Iron Deficiency Anemia
Background: Heavy menstrual bleeding (HMB) is common among adolescents and is an important driver of iron deficiency anemia. However, clinicians under-recognize inherited bleeding disorders. Iron deficiency transiently elevates von Wille...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Vol. 17, no. 1 (FEB 1995)19950517 Notice not published Printed on acid-free paper